2-Fluoro-6-nitro-N-phenylbenzamide: A Critical Pharmaceutical Intermediate for Idelalisib Synthesis
Discover the essential role of this high-purity compound in creating advanced therapeutic agents.
Get a Quote & SampleProduct Core Value
2-Fluoro-6-nitro-N-phenylbenzamide
This vital light yellow powder intermediate, known by its CAS number 870281-83-7, is a cornerstone in the production of cutting-edge therapeutic agents. Its primary application lies in serving as a critical building block for the synthesis of Idelalisib, a significant drug used in targeted cancer therapies. With a guaranteed purity of ≥98.0%, it meets the stringent demands of the pharmaceutical industry, ensuring consistency and reliability in complex synthesis processes.
- Leverage the high purity of 2-Fluoro-6-nitro-N-phenylbenzamide, assaying ≥98.0%, for reliable pharmaceutical synthesis.
- Explore the synthesis of targeted cancer therapies by utilizing this key intermediate.
- Source with confidence: trust in a chemical intermediate with a well-defined CAS number 870281-83-7 for your research and production needs.
- Benefit from the physical properties of this light yellow powder chemical intermediate, suitable for various handling and processing requirements.
Key Advantages for Your Research & Production
Exceptional Purity for Sensitive Applications
Ensuring a minimum assay of 98.0%, this compound is ideal for delicate pharmaceutical synthesis pathways, supporting the development of high-quality drugs.
Cornerstone for Idelalisib Production
This intermediate is a crucial component in the complex chemical synthesis of Idelalisib, contributing directly to the availability of advanced cancer treatments.
Reliable Physical Properties
The consistent light yellow powder form ensures ease of handling and integration into various chemical processes, supporting efficient production workflows.
Key Applications
Pharmaceutical Synthesis
This compound is indispensable in the multi-step synthesis of complex pharmaceutical molecules, directly impacting the creation of life-saving medications.
Drug Intermediate
As a critical intermediate, it bridges the gap between basic raw materials and the final active pharmaceutical ingredient (API), streamlining drug development processes.
Oncology Drug Development
Its role in the synthesis of Idelalisib highlights its importance in the development of targeted therapies for various forms of cancer.
Fine Chemical Manufacturing
Contributes to the broader fine chemical industry, where precision and purity are paramount for specialized applications and research chemicals.